NCT03108209View on ClinicalTrials.gov

Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Phototoxicity
Interventions
OTHER

Photoderm Max lait SPF50+

Subjects apply Photoderm Max lait SPF50+ at the beginning of their treatment by Vemurafenib/Cobimetinib in prevention of phototoxicities

OTHER

Photoderm Max Stick SPF50+

Subjects apply Photoderm Max Stick SPF50+ at the beginning of their treatment by Vemurafenib/Cobimetinib in prevention of phototoxicities

Trial Locations (1)

Unknown

CHU Nantes, Nantes

All Listed Sponsors
lead

Michele Sayag

INDUSTRY

NCT03108209 - Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment | Biotech Hunter | Biotech Hunter